AF802 Alectinib US20240246927, Control group US11066363, Compound Alectinib US9126931, 366 BDBM50362781 Alecensa CH5424802 US10851092, Example Alectinib 1256580-46-7 CHEMBL1738797
- Xie, S; Sun, Y; Liu, Y; Li, X; Li, X; Zhong, W; Zhan, F; Zhu, J; Yao, H; Yang, DH; Chen, ZS; Xu, J; Xu, S Development of Alectinib-Based PROTACs as Novel Potent Degraders of Anaplastic Lymphoma Kinase (ALK). J Med Chem 64: 9120-9140 (2021)
- Ren, C; Sun, N; Kong, Y; Qu, X; Liu, H; Zhong, H; Song, X; Yang, X; Jiang, B Structure-based discovery of SIAIS001 as an oral bioavailability ALK degrader constructed from Alectinib. Eur J Med Chem 217: (2021)